ESMO European Society for Medical Oncology Company Profile

19:58 EDT 21st June 2018 | BioPortfolio

News Articles [2379 Associated News Articles listed on BioPortfolio]

ESMO 2020 Annual Congress back in Madrid

(European Society for Medical Oncology) ESMO, the leading European professional organization for medical oncology, has announced that the ESMO 2020 Annual Congress will take place from Sept. 18 to 22,...

ESMO 2018 Congress: Securing access to optimal cancer care

(European Society for Medical Oncology) Nearly 25,000 participants from all over the world are expected in Munich, Germany, between Oct. 19-23 to attend the leading international oncology event in Eur...

ESMO emphasises importance of cancer on the global health agenda

(European Society for Medical Oncology) At the 71st World Health Assembly (WHA) in Geneva, Switzerland, ESMO, the leading professional organisation for medical oncology, delivered two statements posit...

ELCC 2018: Heine H. Hansen award given to Fabrice Barlesi

(European Society for Medical Oncology) The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) have announced that the 2018 Heine H. Ha...

ESMO Survey Data Clarify Gender Differences in Oncology

Leaders from the European Society for Medical Oncology discuss survey data on gender gaps in oncology and propose solutions to close these gaps between men and women professionally. Medscape Oncolo...

Patients with Advanced Lung Adenocarcinoma and Complex EGFR Mutations Demonstrate Different Response Rates to TKI Therapy

NewsThe findings are from a large retrospective analysis presented at the European Lung Cancer Congress (ELCC) 2018, held April 11 to 14 in Geneva, Switzerland.

20 years of excellence in gastrointestinal research and practice [WCGI 2018]

(European Society for Medical Oncology) Groundbreaking research will be revealed at this year's ESMO World Congress on Gastrointestinal Cancer (June 20-23, 2018, Barcelona, Spain), celebrating 20 year...

[Comment] Adjuvant therapy for women with high-risk endometrial carcinoma

Identification of optimal therapy for patients with high-risk endometrial carcinoma has been frustrated by near-dichotomous paradigms of surgical treatment in the international community and a scarcit...

Drugs and Medications [53 Associated Drugs and Medications listed on BioPortfolio]

Neutrexin (trimetrexate glucuronate for injection) [MedImmune Oncology, Inc.]

NEUTREXIN (trimetrexate glucuronate for injection)

Mediflex [SAS Group Inc.]

Joint formula 88 max [Sarati International, Inc.]

Fareston [GTx, Inc.]

These highlights do not include all the information needed to use FARESTON® safely and effectively. See full prescribing information for FARESTON®.FARESTON® (toremifene citrate) 60 mg Tablets oral ...

Irinotecan hydrochloride [Jiangsu Hengrui Medicine Co. Ltd]

Irinotecan Hydrochloride Injection

PubMed Articles [6879 Associated PubMed Articles listed on BioPortfolio]

The European Society for Medical Oncology (ESMO) Precision Medicine Glossary.

Precision medicine is rapidly evolving within the field of oncology and has brought many new concepts and terminologies that are often poorly defined when first introduced, which may subsequently lead...

European Society for Medical Oncology (ESMO) position paper on supportive and palliative care.

Oncology has come a long way in addressing patients' quality of life, together with developing surgical, radio-oncological and medical anticancer therapies. However, the multiple and varying needs of ...

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer; A JSMO - ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.

The most recent version of the European Society for Medical Oncology (ESMO) consensus guidelines for the treatment of patients with metastatic colorectal cancer (mCRC) was published in 2016, identifyi...

The ESMO Precision Medicine Glossary.

ESMO-MCBS v1.1: Statistical and Patient Relevant Shortcomings.

Clinical Trials [3139 Associated Clinical Trials listed on BioPortfolio]

Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old Patients

Rhabdomyosarcoma (RMS) stands for the most frequent soft tissue sarcoma in children and, adolescents and young adults (AYA, 15-25-year-old population), accounting for approximately half of...

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

The OMS/DES study is a multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome. This trial brought on the way by specialists of the EPNS (E...

Topical Pharyngeal Anesthesia in Sedated Esophagogastroduodenoscopy

At recent, the number of patients who underwent sedated esophagogastroduodenoscopy has been on the increase. For such patients, whether topical pharyngeal anesthesia is needed remains to b...

Postoperative Delirium - European Society of Anaesthesiology Survey

The ESA is currently preparing a guideline on the management of postoperative delirium (POD), which attempts to reduce the impact of postoperative delirium and provide recommendations for ...

Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)

In cancer patients, pain is one of the most common symptoms. The range of reported prevalence of pain varies from 33% to 64% including different stages of cancer, during or after anticance...

Companies [3165 Associated Companies listed on BioPortfolio]

ESMO European Society for Medical Oncology

European Society for Medical Oncology (ESMO)

European Oncology Nursing Society (EONS)

European Calcified Tissue Society

The European Calcified Tissue Society is a company limited by guarantee. The Company does not have shares or shareholders, but instead it has its members. The day-to-day management of the Society is c...

European Society of Cardiology

The European Society of Cardiology (ESC) represents 80,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular d...

More Information about "ESMO European Society for Medical Oncology" on BioPortfolio

We have published hundreds of ESMO European Society for Medical Oncology news stories on BioPortfolio along with dozens of ESMO European Society for Medical Oncology Clinical Trials and PubMed Articles about ESMO European Society for Medical Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ESMO European Society for Medical Oncology Companies in our database. You can also find out about relevant ESMO European Society for Medical Oncology Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record